ABSTRACT -Urinary cholesterol was determined in follow-up in 2 patients with prostatic adeno~, 3 patients with prostat~e car~no~, 3 patients with ~ar~*~o~ of bladdt~, and 4 patients with carcinoma of kidney. A12 patients revealed marked urinary cholesterol hyperexcretion prior to surgery. Except for-1 patient with prostatic carcinoma, excretion of urinary cholesterol normalized at least six weeks after resection. In 1 remarkable case a localized recurrence of a ~ansurethra~ly resected bladd~ tumor was asso~ated with a marked increase of urinary cho~est~ol excretion six weeks prior to cystoscopy. The results point to a possible future value of this method in monitoring patients with bladder tumors, although additional studies are necessary.
Hy-perexcretion of urinary cholesterol in carcinomas of prostate, kidney, and bladder has been described recently even in early clinical stages of these diseases.1-5 However, the diagnostic value of this parameter seemed to be diminished by the fact that elevated concentrations of urinary cholesterol have been observed in other, nonmalignant diseases of the kidney and urinary tract obstruction, especially prostatic adenoma with residual urine.3*5 Nevertheless, serial determinations of urinary cholesterol could be useful in the monitoring of the clinical course which might be of practical value especially in patients with carcinoma of the bladder.
Material and Methods
Total urinary cholesterol was analyzed in Z-ml. aliquots of twenty-four-hour urine with a gas-liquid chromatographic assay using 4androstenedione
as internal standard and peak-height ratio technique for quantitation. This method has been described in detail previously. 3
The preliminary study included a total of 12 patients, 10 males and 2 females, with an age range of from fifty-three to seventy-six years. The diagnosis of cancer or benign prostatic hyperplasia was proved histopathologically after resection. Only patients with marked urinary cholesterol hyperexcretion prior to surgery were selected for the study.
Results

Prostatic adenoma
Serial determinations of urinary cholesterol were performed in 2 patients with prostatic adenoma and residual urine. A marked elevation of urinary cholesterol (normal range 0.3 to 3.0 mg.l.24 hours, 2 SD) was measured in both cases prior to transurethral resection. After an interval of two to four weeks, urinary cholesterol excretion had normalized and remained in the normal range during the total follow-up time (Fig. 1A) . These findings were associated with normalized urinary flow.
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Prostatic carcinoma
Three patients with prostatic carcinoma could be monitored by urinary cholesterol determinations.
In 2 patients increments of urinary cholesterol excretion was observed up to six weeks after resection which normalized in 1 patient and remained in the other patient, most likely due to persistent obstruction of the urinary tract. A drop of urinary cholesterol was observed in the third patient four weeks after resection which remained normal until the end of the follow-up (Fig. 1B) .
Carcinoma of bladder
Urinary cholesterol was measured in 3 patients with carcinoma of the bladder. All cases showed normal urinary cholesterol excretion within four weeks after transurethral resection. In 1 patient hyperexcretion of urinary cholesterol occurred three months after surgery which was due to a localized recurrence of the bladder tumor (Fig. 1C) .
Carcinoma of kidney
Four patients with carcinoma of the kidney revealed slightly or marked elevations of urinary cholesterol prior to resection which normalized in all six weeks after surgery (Fig. 1D) . 
